Inclusion Criteria:
  -  histologically confirmed head and neck squamous cell carcinoma (HNSCC)
  -  WHO performance status 0-2
  -  clinical stage III patients with bulky T3 primary +/- neck metastasis
  -  all stage IV patients
  -  referral to definitive radiotherapy or chemoradiotherapy or multimodality treatment
Exclusion Criteria:
  -  patients who are not able to sign written informed consent